I think the concern/comment is that in the past, Cytodyn
I think the concern/comment is that in the past, Cytodyn has released data from trials and the SP reacts negatively with good data news from a trial. The theory that Cyodyn is not just releasing a PR with the data from the NASH trial and waiting for a peer-reviewed article to bee released is to try and prevent the SP going down on good news. If the data is presented in a peer reviewed article, the news comes packaged in a highly regarded third party wrapper.
Also, Cytodyn has had less than stellar trial data released in such a way to suggest Leronlimab did not work as well, however usually it is analyzed and the problem is the trial did not have the right protocol or the right enrollment. Trial reports need to reflect the effectiveness of leronlimab as much as possible and not require the world look past a flawed trial. This is more difficult because you don't know what the trial will reveal. Long haulers is a perfect example - the trial showed a whole lot more about the condition and what is needed to run a good trial. If the CD12 trial had been presented as exploration instead of a trial that will lead to an EUA, We would be in a very different situation. Instead of an FDA trash letter, we might have an FDA that is guiding with great motivation an drug that shows great promise.
Cytodyn has had a history of very positive news leading to a lower SP, Anything they do differently is worth it to not waste any positive news on lousy packaging. Math has nothing to do with it, because if it did good trial news would result in higher, not lower SP.
5
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Unlocking Hidden Potential: Levvy AI on the Scene Picture this: you're running an accounting shop and drowning in an ocean of endless tasks, manual entries, and those cursed follow-ups. That's probably the daily grind, right? Well, it looks like Levvy has decided to break those shackles. This company, based over there in Brooklyn, is rolling out these fancy Levvy AI...
Continue Reading
Spin Cycle: SKF Vertevo's Bold New Chapter Well, they've flipped the switch. SKF Vertevo is stepping out with a brand-spanking-new logo and digital vibe, marking a hefty shift as they strut their stuff post-dismantling from SKF's automotive domain. Now, don't just gloss over this like it's another corporate rebranding snore-fest; this change comes with serious strategic...
Continue Reading
Leadership Shake-up in the Energy World Who would've thought? Randall W. Atkins, Ramaco Resources' top gun, has just bagged a primo gig as the top dog at the International Energy Agency's Coal Industry Advisory Board (CIAB). Named by unanimous vote, he's about to steer this ship through the ever-evolving waters of coal's future. Now, I know some folks roll their eyes at...
Continue Reading
Medicare's CJR-X Challenges Hospitals 2028 is setting up to be a year hospitals across the U.S. remember, not with a smile, but likely with clenched teeth. Medicare's CJR-X model is ready to put about 2,217 hospitals in a financial vise over hip, knee, and ankle replacements. Going into effect on January 1, 2028, this mandate turns health networks' profit dreams into a...
Continue Reading
MEDICA 2026: Wincomm and Portwell Join Forces November's got one heck of an event lined up with MEDICA 2026, where Wincomm and Portwell are teaming up to showcase what they've got up their sleeves in medical AI computing. This whole shebang runs from November 16 to 19, with their setup in Hall 12, Stand C76, Düsseldorf, Germany. But why should investors care? Because...
Continue Reading
Well, here's a twist in the pickleball world—DUPR and InBody have struck a deal to bring top-notch body composition tech to the ever-expanding universe of pickleballers. They're merging power players from two different worlds to tap into your performance on the court and your wellness off it. Maybe I'm just jaded from too many marketing pitches, but this one could...
Continue Reading
Mobilizing Aid: A Community in Crisis Not every day you wake up to a story that digs into your gut like this one. The folks at the Green Acres Mobile Home Community in Palm Beach County got dealt a raw deal. A Learjet crash shook their world apart on November 1st, leaving nine lives lost on that flight and sending hundreds of residents scrambling from their homes. It's a...
Continue Reading
Orvana's Uphill Journey in Bolivia If you've been tracking Orvana Minerals (TSX: ORV, OTCQX: ORVMF), you know their Bolivian subsidiary, EMIPA, is in the thick of things. Filtration fixes are making noise, and EMIPA's scrambling to get its financial ducks in a row with some urgent maneuvers. Aiming Higher with Don Mario Orvana's Don Mario plant is trucking along with its...
Continue Reading
Scaling Down: Robotics Meet Your Front Yard Imagine kicking back with a cold one while your new fancy robot takes care of the lawn. Sound like a sci-fi fantasy? Nope, that's the reality Pudu Robotics is peddling with their PUDU TOMO S Series. And boy, they're promising a lot more than just a breather from weekend chores. From Corporate Corridors to Quiet Suburbs Pudu's...
Continue Reading
When Makeup Meets Pajamas: The Perfect Storm Picture this: a makeup brand and a lifestyle label dreaming up a collaboration that sends consumers into a full-blown frenzy. In a whirlwind that lasted just 60 seconds, tarte's latest partnership with Roller Rabbit blazed through stock, cementing its place as a record-breaking phenomenon. Maureen Kelly, tarte’s intrepid CEO,...
Continue Reading
Top 5 Most Recently Viewed Articles
Abeona Therapeutics Gears Up for Healthcare Conference Insights CLEVELAND – Abeona Therapeutics Inc. (Nasdaq: ABEO) is set to make a significant impact at the upcoming Leerink Partners Global Healthcare Conference. The Chief Executive Officer, Vish Seshadri, Ph.D., M.B.A., will represent the company at this esteemed event, showcasing its innovative approaches in the...
Continue Reading
A Growing Global Thirst for AI-Enhanced Research It looks like the folks at Clarivate have struck a chord. Their Web of Science Research Intelligence platform is garnering attention across the globe, embraced by more than 100 institutions spanning 25 countries. When you craft something that taps into a core need, well, people will jump on it—and that's exactly what's...
Continue Reading
Eve Holding, Inc. Announces Q2 2025 Financial Outcomes Eve Holding, Inc. (NYSE: EVEX) recently revealed its financial results for the second quarter of 2025, showcasing remarkable insights into its developments in Urban Air Mobility (UAM). Financial Performance Overview The aerospace innovator, focused on electric Vertical Takeoff and Landing (eVTOL) aircraft, reported a...
Continue Reading
Insights into Recent Insider Activity at Sherwin-Williams A recent insider move has attracted attention as Jorgenrud, President at Sherwin-Williams (NYSE: SHW), has disclosed the acquisition of stock options for 10,860 shares. This strategic decision, which emphasizes confidence in the company's future, provides insight into the inner workings of the firm. Details of the...
Continue Reading
The Southern Banc Company Financial Overview Gates Little, President and Chief Executive Officer of The Southern Banc Company, Inc. (OTCBB: SRNN), shared exciting preliminary results for the recent fiscal year-end quarter, highlighting financial performance for the period ending June 30, 2025. Fourth Quarter Earnings Details For the quarter, the Company reported a net...
Continue Reading